The role of anifrolumab in reshaping the treatment landscape of extra-renal systemic lupus erythematosus

The role of anifrolumab in reshaping the treatment landscape of extra-renal systemic lupus erythematosus

Objective. Systemic lupus erythematosus (SLE) is a multifaceted autoimmune disorder that typically requires management with immunosuppressive and anti-inflammatory treatments. The 2023 guidelines of the European Alliance of Associations for Rheumatology now recommend lowering maintenance glucocorti...

Full description

Saved in:
Bibliographic Details
Main Authors: Fulvia Ceccarelli, Matteo Piga, Alessandra Bortoluzzi, Laura Coladonato, Micaela Fredi, Daniele Mauro, Chiara Tani, Luca Iaccarino
Format: Article
Language:English
Published: PAGEPress Publications 2025-07-01
Series:Reumatismo
Subjects:
Systemic lupus erythematosus
anifrolumab
biologics
remission
low disease activity
Online Access:https://www.reumatismo.org/reuma/article/view/1830
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items